NanoViricides
NNVC
$1.49
Share price
2.76%
Change (1 day)
-56.18%
Change (1 year)
Categories
Market capitalization of NanoViricides (NNVC)
Market cap: $0.01 Billion
As of May 2022 NanoViricides has a market cap of $0.01 Billion. This makes NanoViricides the world's 6110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of NanoViricides from 2007 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.01 B | -59.91% |
| 2021 | $0.04 B | 40.07% |
| 2020 | $0.03 B | 215.06% |
| 2019 | $9.71 M | -30.11% |
| 2018 | $0.01 B | -75.06% |
| 2017 | $0.05 B | -10.5% |
| 2016 | $0.06 B | -8.73% |
| 2015 | $0.06 B | -55.65% |
| 2014 | $0.15 B | -35.95% |
| 2013 | $0.24 B | 221.02% |
| 2012 | $0.07 B | -17.87% |
| 2011 | $0.09 B | -55.35% |
| 2010 | $0.20 B | 81.97% |
| 2009 | $0.11 B | 12.81% |
| 2008 | $0.09 B | 113.89% |
| 2007 | $0.04 B |
End of Day market cap according to different sources
On May 17th, 2022 the market cap of NanoViricides was reported to be:
$0.01 Billion
$0.01 Billion
$0.01 Billion
$0.01 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $79.24 B | 461,024.63% | 🇺🇸 USA |
 Merck MRK | $235.17 B | 1,368,362.59% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $166.53 B | 968,935.05% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $113.65 B | 661,220.93% | 🇬🇧 UK |
 Novavax NVAX | $4.38 B | 25,433.21% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $1.65 B | 9,510.91% | 🇺🇸 USA |